Clearside Biomedical, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Hatteras Venture Funds Divest Clearside Biomedical Shares, Individuals Maintain Small Stakes
Hatteras Venture entities have updated their Schedule 13D filing for Clearside Biomedical, Inc., reporting zero beneficial ownership for the funds while associated individuals retain minor holdings.